brandon-beaber

• 
  brandon-beaber brandon-beaber.bsky.social · 9h
  MS Prognosis is Improving Over Time youtube.com/shorts/5ghnY...
  

  MS Prognosis is Improving Over Time

  YouTube video by Dr. Brandon Beaber

  youtube.com
  Repost Quote post

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels
• 
  brandon-beaber brandon-beaber.bsky.social · Feb 5
  Glatiramer in progressive MS? This small open label unrandomized tial in PPMS with a long acting depot injection showed stable disability (mean EDSS 5.1 at baseline and 4.5 at 3 years), though the rate of brain atrophy was similar untreated progressive MS www.abstractsonline.com/pp8/#!/21408...

  Program Planner

  abstractsonline.com
  Repost Quote post

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels
• 
  brandon-beaber brandon-beaber.bsky.social · Feb 4
  Multiple Sclerosis MRI Findings Explained by Neurologist youtu.be/ftc9wvJCW9s?...
  

  Multiple Sclerosis MRI Findings Explained by Neurologist

  YouTube video by Dr. Brandon Beaber

  youtu.be
  Repost Quote post

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels
• 
  brandon-beaber brandon-beaber.bsky.social · Feb 2
  Can testing Neurofilament Light Chain predict whether people with multiple sclerosis will respond to a certain medication? Not really. This analysis from Sweden suggests clinical and demographic factors are more prognostic. onlinelibrary.wiley.com/doi/10.1111/...
  

  Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis

  This graphical abstract shows that serum NfL was evaluated alongside clinicodemographic variables that were reduced using principal component analysis (PCA). These components were then incorporated i....

  onlinelibrary.wiley.com
  Repost Quote post

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels